{
  "actions": [
    {
      "acted_at": "2019-05-01",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2019-05-01",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the House Committee on Energy and Commerce.",
      "type": "referral"
    },
    {
      "acted_at": "2019-05-02",
      "action_code": "",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "text": "Referred to the Subcommittee on Health.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr2455-116",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF",
      "subcommittee": "Subcommittee on Health",
      "subcommittee_id": "14"
    }
  ],
  "congress": "116",
  "cosponsors": [
    {
      "bioguide_id": "B001308",
      "district": "22",
      "name": "Brindisi, Anthony",
      "original_cosponsor": true,
      "sponsored_at": "2019-05-01",
      "state": "NY",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "C001121",
      "district": "6",
      "name": "Crow, Jason",
      "original_cosponsor": false,
      "sponsored_at": "2019-05-28",
      "state": "CO",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "F000466",
      "district": "1",
      "name": "Fitzpatrick, Brian K.",
      "original_cosponsor": false,
      "sponsored_at": "2019-06-05",
      "state": "PA",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "S001199",
      "district": "11",
      "name": "Smucker, Lloyd",
      "original_cosponsor": false,
      "sponsored_at": "2019-06-13",
      "state": "PA",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "W000823",
      "district": "6",
      "name": "Waltz, Michael",
      "original_cosponsor": false,
      "sponsored_at": "2019-05-28",
      "state": "FL",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "W000827",
      "district": "6",
      "name": "Wright, Ron",
      "original_cosponsor": false,
      "sponsored_at": "2019-05-28",
      "state": "TX",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2019-05-01",
  "number": "2455",
  "official_title": "To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions.",
  "popular_title": null,
  "related_bills": [
    {
      "bill_id": "s1169-116",
      "identified_by": "CRS",
      "reason": "identical",
      "type": "bill"
    },
    {
      "bill_id": "s3384-116",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    }
  ],
  "short_title": "Ensuring Timely Access to Generics Act of 2019",
  "sponsor": {
    "bioguide_id": "J000302",
    "district": "13",
    "name": "Joyce, John",
    "state": "PA",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2019-05-01",
  "subjects": [
    "Administrative remedies",
    "Department of Health and Human Services",
    "Drug safety, medical device, and laboratory regulation",
    "Food and Drug Administration (FDA)",
    "Government information and archives",
    "Health",
    "Prescription drugs"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2019-05-01",
    "date": "2021-09-12T19:05:33Z",
    "text": "Ensuring Timely Access to Generics Act of 2019\n\nThis bill requires the Food and Drug Administration (FDA) to consider certain factors in determining whether a petition is submitted for the primary purpose of delaying the approval of a drug application.\n\nThe FDA must (1) publish a list of petitions that were submitted with an intent to delay, and (2) establish procedures to refer such petitions to the Federal Trade Commission.\n\nThe FDA may establish a timeline for submitting petitions."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Ensuring Timely Access to Generics Act of 2019",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions.",
      "type": "official"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Ensuring Timely Access to Generics Act of 2019",
      "type": "short"
    }
  ],
  "updated_at": "2022-02-08T23:19:36Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/116/hr/BILLSTATUS-116hr2455.xml"
}